We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AC:EURONEXT PARISAccor SA Analysis

Data as of 2026-03-13 - not real-time

$196.65

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Accenture plc is trading at $196.65, well below its DCF fair value of $317.57 and the 43% upside implied by that model. The stock sits beneath its 20‑day SMA of 208.18 and the 50‑day SMA of 242.28, signaling a short‑term bearish bias, yet the RSI of 32.6 indicates oversold conditions that could trigger a rebound. Technical momentum is modestly positive, with a bullish MACD signal and a small positive histogram, while price remains above the key support level of $188.73 and below resistance at $229.11. Fundamental metrics reinforce the undervaluation: a PE of 16.3 versus an industry average of 33.7, a solid ROE of 25%, and a generous 3.33% dividend yield supported by a 50% payout ratio and strong free cash flow. The company’s growth outlook remains robust, driven by AI and cloud partnerships, and its balance sheet is healthy with a low debt‑to‑equity of 25.7%.
Given the combination of technical oversold signals, strong cash generation, and a sizable valuation gap, Accenture presents a compelling buying opportunity for investors with a medium to long horizon, while short‑term traders may prefer a cautious hold pending confirmation of a price bounce.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • RSI in oversold territory suggesting a potential bounce
  • Bullish MACD signal despite price below short‑term SMA
  • Support level at $188.73 providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap (DCF upside >40%)
  • Strong free cash flow and sustainable dividend yield
  • Growth drivers in AI, cloud, and digital transformation services

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust ROE and consistent earnings growth
  • Strategic partnerships with AWS and OpenAI enhancing future revenue
  • Low beta and diversified global client base reducing systemic risk

Key Metrics & Analysis

Financial Health

Revenue Growth6.00%
Profit Margin10.76%
P/E Ratio16.3
ROE25.02%
ROA11.13%
Debt/Equity25.69
P/B Ratio3.9
Op. Cash Flow$12.1B
Free Cash Flow$11.1B
Industry P/E33.7

Technical Analysis

TrendBearish
RSI32.6
Support$188.73
Resistance$229.11
MA 20$208.18
MA 50$242.28
MA 200$259.53
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value$317.57
Target Price$282.25
Upside/Downside43.53%
GradeUndervalued
TypeBlend
Dividend Yield3.33%

Risk Assessment

Beta0.85
Volatility52.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.